Furthermore, they are also supportive of our previous results, wherein we observed an elevated in vitro and in vivo anti-tumor efficacy of a combination approach of combination of p53 and miR-125b in in vitro and in vivo studies with Kras G12D cell lines and animals.25 This evidence concerns the gene TP53 and neoplasm.